A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs

por Funch, D, Gydesen, H, Tornøe, K, Major-Pedersen, A, Chan, K A
Publicado 2014

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled tr...

por Ahmann, A., Rodbard, H. W., Rosenstock, J., Lahtela, J. T., de Loredo, L., Tornøe, K., Boopalan, A., Nauck, M. A.
Publicado 2015

Efficacy and safety of liraglutide compared to sulphonylurea during Ramadan in patients with type 2 diabetes (LIRA‐Ramadan): a randomized trial

por Azar, S. T., Echtay, A., Wan Bebakar, W. M., Al Araj, S., Berrah, A., Omar, M., Mutha, A., Tornøe, K., Kaltoft, M. S., Shehadeh, N.
Publicado 2016